Voyager Therapeutics Inc (VYGR): Qarzning balans kapitallashuviga nisbati
Voyager Therapeutics (VYGR) demensiya va Parkinson kasalligiga qarshi kurashish uchun miyaga yo'naltirilgan ilg'or gen terapiyasi yetkazib berish tizimlarini ishlab chiqadi. Ushbu kunlik narxlar grafigi 0.22 bozor kapitalizatsiyasi bilan aktivning dinamikasini aks ettiradi. Biznes modeli global korporatsiyalarga xususiy viral vektorlarni litsenziyalashga asoslangan. Bundan tashqari, patentlangan TRACER IT tizimi organizmning biologik filtrlarini chetlab o'tish imkonini beradi, bu esa raqobatchilar uchun yengib bo'lmas texnologik to'siqni yaratadi.
&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_VYGR_-_Voyager-Therapeutics_-_Debt-to-Net-Assets-Ratio "VYGR: Voyager Therapeutics, Inc. Qarzning balans kapitallashuviga nisbati 04.07.2022 - 30.10.2026 | 👁️GURU.Markets👁️")
VYGR (Voyager Therapeutics Inc): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar
- aksiya narxi va konsensus maqsadli narx:
- birja kapitallashuvi ma'lumotlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati Voyager Therapeutics|VYGR - Uzoq muddatli majburiyatlarning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Voyager Pharma|VYGR - Kompaniyaning umumiy yig'indi qarzi|Balans kapitallashuviga qarzlar Voyager Corp|VYGR - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Voyager Therapeutics|Tezkor likvidlik koeffitsiyenti voyagertherapeutics.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
Kompaniyaning dastlabki tahlili:Voyager Therapeutics VYGR
Barqaror aktivlarning professional tanlovi biznesning moliyaviy avtonomiyasini baholash uchun umumiy majburiyatlarning kapitalga nisbatini tahlil qilishni talab qiladi. GURU.Markets platformasidagi qarzdorlikning kapitalga nisbati dinamikasi Voyager Therapeutics (VYGR) kompaniyasining leveraj darajasini ko'rsatadi, bu esa kompaniyaning gen terapiyasi ishlanmalari muvaffaqiyatiga va sog'liqni saqlash gigantlari bilan uzoq muddatli sherikliklarga bog'liqligini hisobga olganda juda muhimdir.
Voyager Therapeutics raqobatchilari
Biogen Inc. - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar neurocrine.com NBIX|RGC - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati AXSM (Axsome)|ACADIA Pharmaceuticals Inc (ACAD) - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar Xenon Corp (XENE)|Qarzning balans qiymatiga nisbati VKTX|Qarzning balans kapitallashuviga nisbati SUPN|Qarzning balans kapitallashuviga nisbati Catalyst Pharmaceuticals, Inc. (CPRX)|DNLI - Balans qiymatiga qarzlar|Harmony Pharma - Qarzning balans qiymatiga nisbati|Biohaven Corp (BHVN) - Balans qiymatiga qarzlar|Amylyx Pharmaceuticals - Balans kapitallashuviga qarzlar|TRVI - Balans kapitallashuviga qarzlar|PRAX: Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Anavex AVXL|CBLL (CeriBell Corp) - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar prothena.com PRTA|Qarzning balans kapitallashuviga nisbati Alector, Inc. (ALEC)|ANNX (annexonbio.com) - Qarzning sof aktivlarga nisbati|Omeros - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati NGNE|ACIU: Qarzning balans qiymatiga nisbati|Neumora Corp - Qarzning balans kapitaliga nisbati|SCLX: Balans kapitallashuviga qarzlar|tevogen.com - Qarzning sof aktivlarga nisbati|ACOG (Alpha Cognition Inc) - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Cognition Therapeutics Inc. CGTX|Qarzning balans kapitallashuviga nisbati Inhibikase (IKT)|SAVA (Cassava Pharma) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar ASRT (Assertio)|Balans kapitallashuviga qarzlar Coya Therapeutics Inc COYA|VTGN - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati OVID|ABOS: Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar CervoMed Corporation (CRVO)|Qarzning balans qiymatiga nisbati ATHE|Balans kapitallashuviga qarzlar Clene Nanomedicine|Qarzning balans qiymatiga nisbati PEPG (PepGen Inc.)|Qarzning balans kapitaliga nisbati JUNS|Balans kapitallashuviga qarzlar RLMD (Relmada)|Sof aktivlarga qarzlar Annovis Bio Corporation (ANVS)|Grace Tx - Balans kapitallashuviga qarzlar|fireflyneuro.com (AIFF) - Qarzning balans qiymatiga nisbati|anewmeds.com (KLTO) - Qarzning balans kapitallashuviga nisbati|NRSN - Sof aktivlarga qarzlar|Qarzning balans qiymatiga nisbati RVPH|Qarzning balans kapitallashuviga nisbati MTVA|Qarzning balans qiymatiga nisbati NRXS (NeurAxis, Inc.)|HSDT - Balans qiymatiga qarzlar|Balans kapitallashuviga qarzlar PASG (Passage Bio)|Qarzning sof aktivlarga nisbati Neuphoria Therapeutics, Inc.|NERV - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati ATHA (Athira Pharma Corp)|Addex Therapeutics (ADXN) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati ALZN|CYCN (Cyclerion Therapeutics Inc.) - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Protagenic PTIX|Qarzning balans qiymatiga nisbati KTTA (Pasithea Therapeutics)|Balans kapitallashuviga qarzlar cortigent.com (CRGT)|Qarzning balans kapitallashuviga nisbati Avenue Therapeutics ATXI|Qarzning sof aktivlarga nisbati BCLI|CARA - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar Chromocell Therapeutics Corp|ELYM (eliemtx.com) - Qarzning balans qiymatiga nisbati|ITCI (Intra-Cellular Therapies, Inc.) - Qarzning balans kapitallashuviga nisbati|Qarzning balans kapitallashuviga nisbati Longboard Pharmaceuticals|Balans qiymatiga qarzlar marinuspharma.com MRNS|Qarzning balans qiymatiga nisbati NKGN (NKGen Biotech)|NRBO - Balans qiymatiga qarzlar|Balans kapitallashuviga qarzlar SAGE (Sage Therapeutics, Inc)|Balans kapitallashuviga qarzlar Synaptogenix, Inc SNPX|Trevena, Inc. - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Vigil Neuroscience (VIGL)|WENA: Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Cerevel Therapeutics Inc (CERE)